<unk>  is a histone deacetylase inhibitor that is FDA approved for the treatment of cutaneous T-cell lymphoma (CTCL), peripheral T-cell lymphoma (PTCL).   Common adverse reactions include EKG ST segment changes, anemia, neutropenia,  infectious disease, cutaneous T-cell lymphoma, lymphocytopenia.
Romidepsin
Dolastetron 
Mephenesin
Clebopride
Palonosetron
Sultopride
Guacetisal
Oxyphenisatine